Simplify Asset Management Inc. Buys Shares of 1,085 Synopsys, Inc. $SNPS

Simplify Asset Management Inc. purchased a new position in Synopsys, Inc. (NASDAQ:SNPSFree Report) during the 3rd quarter, HoldingsChannel reports. The firm purchased 1,085 shares of the semiconductor company’s stock, valued at approximately $535,000.

Several other hedge funds also recently modified their holdings of the business. Lionshead Wealth Management LLC increased its position in Synopsys by 1.9% during the second quarter. Lionshead Wealth Management LLC now owns 914 shares of the semiconductor company’s stock worth $469,000 after acquiring an additional 17 shares during the period. YANKCOM Partnership increased its holdings in shares of Synopsys by 3.3% during the 2nd quarter. YANKCOM Partnership now owns 537 shares of the semiconductor company’s stock worth $275,000 after purchasing an additional 17 shares during the period. Manchester Capital Management LLC increased its holdings in shares of Synopsys by 5.3% during the 2nd quarter. Manchester Capital Management LLC now owns 340 shares of the semiconductor company’s stock worth $174,000 after purchasing an additional 17 shares during the period. Hemington Wealth Management raised its position in shares of Synopsys by 10.1% during the second quarter. Hemington Wealth Management now owns 197 shares of the semiconductor company’s stock valued at $100,000 after buying an additional 18 shares during the last quarter. Finally, Concord Asset Management LLC VA lifted its stake in shares of Synopsys by 0.8% in the second quarter. Concord Asset Management LLC VA now owns 2,379 shares of the semiconductor company’s stock valued at $1,220,000 after buying an additional 18 shares during the period. 85.47% of the stock is owned by institutional investors.

Synopsys Stock Performance

Synopsys stock opened at $478.97 on Tuesday. The firm has a market capitalization of $91.64 billion, a P/E ratio of 59.95, a P/E/G ratio of 3.97 and a beta of 1.16. The stock has a fifty day moving average price of $438.09 and a two-hundred day moving average price of $503.51. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52.

Synopsys (NASDAQ:SNPSGet Free Report) last issued its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, beating the consensus estimate of $2.79 by $0.11. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The firm’s revenue for the quarter was up 37.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $3.40 EPS. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. As a group, analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the sale, the chief financial officer owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 0.62% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. BNP Paribas initiated coverage on Synopsys in a research note on Thursday, October 2nd. They set an “underperform” rating and a $425.00 price target on the stock. Wells Fargo & Company boosted their price objective on Synopsys from $445.00 to $500.00 and gave the company an “equal weight” rating in a research report on Thursday, December 11th. Morgan Stanley raised their target price on Synopsys from $510.00 to $550.00 and gave the stock an “overweight” rating in a research report on Friday, December 12th. Bank of America upgraded shares of Synopsys from an “underperform” rating to a “neutral” rating and decreased their price target for the stock from $525.00 to $500.00 in a research note on Monday, December 8th. Finally, Rosenblatt Securities upgraded shares of Synopsys from a “neutral” rating to a “buy” rating and dropped their price objective for the company from $605.00 to $560.00 in a research note on Tuesday, December 9th. Eleven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $562.13.

Get Our Latest Stock Analysis on Synopsys

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

See Also

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.